SCHEMBL24331569

SCHEMBL24331569

C(#Cc1c[nH]c2ccccc12)c1ccc2oc(N3CCOCC3)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.46
▸ PRKDC P78527 2/20 0.43
▸ XRCC6 P12956 1/20 0.43
▸ XRCC5 P13010 1/20 0.43
▸ HCRTR2 O43614 2/20 0.42
▸ FAAH O00519 1/20 0.41
▸ HCRTR1 O43613 1/20 0.40
▸ PRKCB P05771 1/20 0.39
▸ PRKCA P17252 1/20 0.39
▸ PRKCH P24723 1/20 0.39
▸ PRKCE Q02156 1/20 0.39
▸ PRKCQ Q04759 1/20 0.39
▸ PRKCD Q05655 1/20 0.39
▸ HTR6 P50406 1/20 0.38
▸ MGLL Q99685 1/20 0.38
▸ PDE2A O00408 1/20 0.37
▸ PDGFRB P09619 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30611143 1.00 ELANE (0.46) ELANEPRKDCXRCC6XRCC5HCRTR2
SCHEMBL30611139 0.82 ELANE (0.46) ELANEPRKDCXRCC6XRCC5FAAH
SCHEMBL24330120 0.82 ELANE (0.46) ELANEPRKDCXRCC6XRCC5FAAH
SCHEMBL26912467 0.78 MAPT (0.53) PRKCBPRKCAPRKCHPRKCEPRKCQ
SCHEMBL30611169 0.77 ELANE (0.46) ELANEPRKDCXRCC6XRCC5HCRTR2
SCHEMBL24331552 0.77 ELANE (0.46) ELANEPRKDCXRCC6XRCC5HCRTR2
SCHEMBL24330163 0.74 HCRTR2 (0.50) ELANEPRKDCXRCC6XRCC5HCRTR2
SCHEMBL24330110 0.74 FAAH (0.53) ELANEPRKDCXRCC6XRCC5FAAH
SCHEMBL30611150 0.74 CYP2D6 (0.48) ELANEPRKDCXRCC6XRCC5HCRTR2
SCHEMBL24331227 0.74 CYP2D6 (0.48) ELANEPRKDCXRCC6XRCC5HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391774-A1 Novel Compounds AC IMMUNE SA (CH) 2023-12-07 — — US claimed
CN-116568684-A Novel compounds AC免疫有限公司 2023-08-08 — — CN claimed
US-20230391774-A1 Novel Compounds AC IMMUNE SA (CH) 2023-12-07 — — US disclosed
CN-116568684-A Novel compounds AC免疫有限公司 2023-08-08 — — CN disclosed
WO-2022078971-A1 NOVEL COMPOUNDS AC IMMUNE SA (CH) 2022-04-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391774-A1 Novel Compounds MAPT, PSEN2, PSEN1 ELANE 2173/4885PRKDC 3877/4885XRCC6 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback